Abstract:Abstract Background: Transgelin, an actin-binding protein, is associated with the cytoskeleton remodeling. Our previous studies found that transgelin was up-regulated in node-positive colorectal cancer versus in node-negative disease. Over-expression of TAGLN affected the expression of 256 downstream transcripts and increased the metastatic potential of colon cancer cells in vitro and in vivo. This study aims to explore the mechanisms that transgelin participates in the metastasis of colon cancer cells.Methods: Immunofluorescence and immunoblotting analysis were used to determine the cellular localization of the endogenous and exogenous transgelin in colon cancer cells. Co-immunoprecipitation and subsequent high performance liquid chromatography/tandem mass spectrometry were performed to identify the proteins potentially interacting with transgelin. Bioinformatics methods were used to analyze the 256 downstream transcripts regulated by transgelin to discriminate the specific key genes and signaling pathways. GCBI tools were used to predict the potential transcription factor(s) for these key genes. The predicted transcription factors were matching to the proteins that have been identified to interact with transgelin. The interaction between transgelin and these transcription factors was verified by co-immunoprecipitation and immunofluorescence.Results: Transgelin was found to localize both in cytoplasm and nucleus of colon cancer cells. 297 proteins have been identified to interact with transgelin by co-immunoprecipitation and subsequent high performance liquid chromatography/mass spectrometry. Over-expression of TAGLN could lead to differential expression of 184 downstream genes. The network of gene-encoded proteins was constructed in which 7 genes (CALM1, MYO1F, NCKIPSD, PLK4, RAC1, WAS and WIPF1) have been discriminated as key genes by network topology analysis. They are mostly involved in the Rho signaling pathway. Poly ADP-ribose polymerase-1 (PARP1) was predicted as the unique transcription factor for the key genes and concurrently matching to the DNA-binding proteins potentially interacting with transgelin. Immunoprecipitation and immunofluorescence validated the interaction between PARP1and transgelin in human RKO colon cancer cells. Conclusions: The results of this study suggest that transgelin binds to PARP1 and regulates the expression of downstream key genes which are mainly involved in Rho signaling pathway, thus participates in the metastasis of colon cancer.

Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling.

Overexpression of Gelsolin Reduces the Proliferation and Invasion of Colon Carcinoma Cells

Gelsolin-mediated Activation of PI3K/Akt Pathway is Crucial for Hepatocyte Growth Factor-Induced Cell Scattering in Gastric Carcinoma.

Widespread Loss Of Gelsolin In Breast Cancers Of Humans, Mice, And Rats

Concurrent Down-Regulation of Egr-1 and Gelsolin in the Majority of Human Breast Cancer Cells.

Transgelin Increases Metastatic Potential of Colorectal Cancer Cells in Vivo and Alters Expression of Genes Involved in Cell Motility

Lower Expression of Gelsolin in Colon Cancer and Its Diagnostic Value in Colon Cancer Patients

Inhibition of Migration and Invasion of Gastric Cancer Cells by Snail-Regulated Mir-375 Through Jak2 Targeting

ANGPTL1 Attenuates Colorectal Cancer Metastasis by Up-Regulating Microrna-138

A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.

Molecular mechanism of transcriptional repression of gelsolin in human breast cancer cells.

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

Transgelin interacts with PARP1 and affects Rho signaling pathway in human colon cancer cells

Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients

EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway

Discovery and Verification of Gelsolin As a Potential Biomarker of Colorectal Adenocarcinoma in a Chinese Population: Examining Differential Protein Expression Using an Itraq Labelling-Based Proteomics Approach

G protein pathway suppressor 2 suppresses gastric cancer by destabilizing epidermal growth factor receptor

AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression

Upregulation of Transgelin is an Independent Factor Predictive of Poor Prognosis in Patients with Advanced Pancreatic Cancer.

Gelsolin: A comprehensive pan-cancer analysis of potential prognosis, diagnostic, and immune biomarkers

Gelsolin Regulates Proliferation, Apoptosis and Invasion in Natural Killer/t-Cell Lymphoma Cells